FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091270918> ?p ?o ?g. }

• W2091270918 abstract "Alendronate has been developed for the treatment of diseases characterized by increased bone resorption, such as osteoporosis. It increases metaphyseal bone density, bone volume, femoral bending strength and vertebral compressive strength, in a dose-dependent manner, in growing, intact rats. In ovariectomized (OVX) rats, alendronate increases femoral bone mass and tibial trabecular bone volume in a dose-dependent manner, and increases femoral midshaft bending strength. In rats immobilized by unilateral sciatic neurectomy, it inhibits bone loss and is dose-dependent. In rats, alendronate prevents high-turnover osteopenia induced by hyperthyroidism or by administration of immunosuppressant agent cyclosporin-A. Also in rats, treatment with prostaglandin E2 and alendronate does not inhibit prostaglandin E2-induced stimulation of bone formation on endocortical and periosteal surfaces. It does, however, prevent prostaglandin E2-induced cortical bone porosity as a result of increased bone resorption, leading to an increase in cortical thickness and an increase in three-point bending strength of the femoral midshaft. At up to five times the dose used for treatment of osteoporosis in clinical trials, alendronate causes no abnormalities in bone remodeling, bone structure, or structural mechanical properties of the femur or vertebrae in intact beagles. Treatment with alendronate before or during fracture healing, or both, has no adverse effects on the union, strength, bone formation or mineralization of bone in mature beagle dogs. In intact minipigs, sodium fluoride increases and alendronate decreases bone turnover, while sodium fluoride, but not alendronate, decreases L4 strength and femoral stiffness. Small-angle X-ray scattering and backscattered electron imaging show that the trabecular bone matrix is more uniformly mineralized after alendronate treatment. In OVX baboons, which show bone changes similar to those seen in postmenopausal women, alendronate prevents an increase in bone turnover, and increases both bone volume and strength in vertebrae, in a dose-dependent manner. Alendronate also reduces the bone loss of alveolar support associated with periodontitis in monkeys. Thus, alendronate inhibits bone resorption and bone turnover, increases bone quantity accompanied by improved bone quality in some of the intact animals and in the animal models." @default.
• W2091270918 created "2016-06-24" @default.
• W2091270918 creator A5006314843 @default.
• W2091270918 creator A5030078651 @default.
• W2091270918 creator A5042012204 @default.
• W2091270918 date "1999-09-01" @default.
• W2091270918 modified "2023-09-26" @default.
• W2091270918 title "PRECLINICAL STUDIES OF ALENDRONATE" @default.
• W2091270918 cites W1971689675 @default.
• W2091270918 cites W1977154179 @default.
• W2091270918 cites W1981500253 @default.
• W2091270918 cites W1993655183 @default.
• W2091270918 cites W1993951873 @default.
• W2091270918 cites W2001436315 @default.
• W2091270918 cites W2012954821 @default.
• W2091270918 cites W2014375336 @default.
• W2091270918 cites W2019437481 @default.
• W2091270918 cites W2020365883 @default.
• W2091270918 cites W2022641698 @default.
• W2091270918 cites W2025785481 @default.
• W2091270918 cites W2028460487 @default.
• W2091270918 cites W2061235833 @default.
• W2091270918 cites W2081588688 @default.
• W2091270918 cites W2086679375 @default.
• W2091270918 cites W2093655961 @default.
• W2091270918 cites W2104134230 @default.
• W2091270918 cites W2129860620 @default.
• W2091270918 cites W2144210769 @default.
• W2091270918 cites W2158336699 @default.
• W2091270918 cites W2336678594 @default.
• W2091270918 cites W2991587873 @default.
• W2091270918 doi "https://doi.org/10.1142/s0218957799000221" @default.
• W2091270918 hasPublicationYear "1999" @default.
• W2091270918 type Work @default.
• W2091270918 sameAs 2091270918 @default.
• W2091270918 citedByCount "2" @default.
• W2091270918 countsByYear W20912709182012 @default.
• W2091270918 crossrefType "journal-article" @default.
• W2091270918 hasAuthorship W2091270918A5006314843 @default.
• W2091270918 hasAuthorship W2091270918A5030078651 @default.
• W2091270918 hasAuthorship W2091270918A5042012204 @default.
• W2091270918 hasConcept C105702510 @default.
• W2091270918 hasConcept C126322002 @default.
• W2091270918 hasConcept C126894567 @default.
• W2091270918 hasConcept C134018914 @default.
• W2091270918 hasConcept C141071460 @default.
• W2091270918 hasConcept C146562846 @default.
• W2091270918 hasConcept C170033053 @default.
• W2091270918 hasConcept C185592680 @default.
• W2091270918 hasConcept C2776541429 @default.
• W2091270918 hasConcept C2776886416 @default.
• W2091270918 hasConcept C2777083390 @default.
• W2091270918 hasConcept C2777251235 @default.
• W2091270918 hasConcept C2779329777 @default.
• W2091270918 hasConcept C2779809032 @default.
• W2091270918 hasConcept C2780554211 @default.
• W2091270918 hasConcept C2781451080 @default.
• W2091270918 hasConcept C2911223091 @default.
• W2091270918 hasConcept C673006 @default.
• W2091270918 hasConcept C71924100 @default.
• W2091270918 hasConceptScore W2091270918C105702510 @default.
• W2091270918 hasConceptScore W2091270918C126322002 @default.
• W2091270918 hasConceptScore W2091270918C126894567 @default.
• W2091270918 hasConceptScore W2091270918C134018914 @default.
• W2091270918 hasConceptScore W2091270918C141071460 @default.
• W2091270918 hasConceptScore W2091270918C146562846 @default.
• W2091270918 hasConceptScore W2091270918C170033053 @default.
• W2091270918 hasConceptScore W2091270918C185592680 @default.
• W2091270918 hasConceptScore W2091270918C2776541429 @default.
• W2091270918 hasConceptScore W2091270918C2776886416 @default.
• W2091270918 hasConceptScore W2091270918C2777083390 @default.
• W2091270918 hasConceptScore W2091270918C2777251235 @default.
• W2091270918 hasConceptScore W2091270918C2779329777 @default.
• W2091270918 hasConceptScore W2091270918C2779809032 @default.
• W2091270918 hasConceptScore W2091270918C2780554211 @default.
• W2091270918 hasConceptScore W2091270918C2781451080 @default.
• W2091270918 hasConceptScore W2091270918C2911223091 @default.
• W2091270918 hasConceptScore W2091270918C673006 @default.
• W2091270918 hasConceptScore W2091270918C71924100 @default.
• W2091270918 hasLocation W20912709181 @default.
• W2091270918 hasOpenAccess W2091270918 @default.
• W2091270918 hasPrimaryLocation W20912709181 @default.
• W2091270918 hasRelatedWork W1972485379 @default.
• W2091270918 hasRelatedWork W2001436315 @default.
• W2091270918 hasRelatedWork W2002797656 @default.
• W2091270918 hasRelatedWork W2005074915 @default.
• W2091270918 hasRelatedWork W2025535784 @default.
• W2091270918 hasRelatedWork W2057739263 @default.
• W2091270918 hasRelatedWork W2073812183 @default.
• W2091270918 hasRelatedWork W2077408597 @default.
• W2091270918 hasRelatedWork W2083775310 @default.
• W2091270918 hasRelatedWork W2092726458 @default.
• W2091270918 hasRelatedWork W2093662953 @default.
• W2091270918 hasRelatedWork W2098530749 @default.
• W2091270918 hasRelatedWork W2144393960 @default.
• W2091270918 hasRelatedWork W2337513051 @default.
• W2091270918 hasRelatedWork W2371686175 @default.
• W2091270918 hasRelatedWork W2397019667 @default.
• W2091270918 hasRelatedWork W2568455980 @default.
• W2091270918 hasRelatedWork W2611210216 @default.

• next